Tumor-Associated Antigens for Diagnosis and Therapy

Simple SummaryContent extracted from patent full text and abstract with AI.

This invention relates to pharmaceutical compositions and methods for detecting or inhibiting the expression or activity of tumor-associated antigens for the diagnosis and treatment of cancer. It provides targeted molecules and techniques to identify or interfere with specific antigens found in tumors, improving diagnosis and therapy options for cancer patients.

Use CasesContent extracted from patent full text and abstract with AI.

• Early detection of cancers using assays that identify tumor-associated antigens in patients.
• Development of targeted cancer therapies that inhibit certain tumor-associated antigens.
• Monitoring cancer treatment effectiveness through measurement of antigen activity or expression levels.
• Personalized medicine approaches based on specific tumor antigen profiles in patients.
• Companion diagnostics for newly developed cancer drugs.

BenefitsContent extracted from patent full text and abstract with AI.

• Potential for more accurate and earlier cancer diagnosis.
• Targeted therapies can reduce harm to healthy cells compared to traditional treatments.
• Personalized treatment options could improve patient outcomes.
• Ability to monitor disease progression and response to treatment more effectively.
• May enable development of new drugs and diagnostics for hard-to-treat cancers.

Technical Classifications (CPCs)

Inventors & Applicants

Patent Abstract

Die Erfindung betrifft eine Pharmazeutische Zusammensetzung, umfassend ein Mittel, das die Expression oder Aktivität eines Tumor-assoziierten Antigens nachweist oder inhibiert, sowie ein Verfahren zur Behandlung und Diagnose einer Tumorerkrankung. Diese Mittel und Verfahren ermöglichen es Zielstrukturen für eine Diagnose und Therapie von Erkrankungen, insbesondere Krebserkrankungen bereit zu stellen.